Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Conditions
Interventions
Control Intervention1: IV lignocaine, IV Dexmedetomidine and IV Ketamine: One group (Group OFA) will receive IV lignocaine 1.5mg/kg, IV Dexmedetomidine 0.5 mcg/kg and IV Ketamine 0.5 mg/kg during indu
Sponsors
DEPARTMENT OF ONCOANAESTHESIA PAIN AND PALLIATIVE CARE
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient aged 18-60 years posted for head and neck cancer surgery. 2. Patient belonging to ASA I-II.
Exclusion criteria
Exclusion criteria: 1. Any known allergy to study drugs. 2.Patient with bradycardia(HR 3.Surgeries exceeding > 5hrs. 4. Patients on ventilator in the postoperative period. 5.Patient refusal.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the intubation response and propofol requirement in both the groupsTimepoint: During induction and intubation | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To compare the haemodynamic parameters in both the groups during the intraoperative period. 2.To compare the analgesic consumption in the 24 hr postoperative period. 3.To observe for any side effects in both the groups.Timepoint: Intraoperatively and postoperatively | — |
Countries
India
Contacts
Public ContactArnav Das
STATE CANCER INSTITUTE
Outcome results
None listed